Article
Pathological mutations reveal the key role of the iRhom2 N-terminus for ADAM17 binding…
medRxiv · 2023 · Bläsius, K.; Ludwig, L.; Knapp, S.; Flasshove, C.; Sonnabend, F.; Keller, D.; Tacken, N.; Gao, X.; Kahveci, S.; Grannemann, C.; Babendreyer, A.; Adrain, C.; Huth, S.; Baron, J.; Ludwig, A.; Düsterhöft, S.
Key facts
| Title | Pathological mutations reveal the key role of the iRhom2 N-terminus for ADAM17 binding, stability and activity. |
|---|---|
| First author | Bläsius, K.; Ludwig, L.; Knapp, S.; Flasshove, C.; Sonnabend, F.; Keller, D.; Tacken, N.; Gao, X.; Kahveci, S.; Grannemann, C.; Babendreyer, A.; Adrain, C.; Huth, S.; Baron, J.; Ludwig, A.; Düsterhöft, S. |
| Journal | medRxiv |
| Published | Nov 27, 2023 |
| DOI | 10.1101/2023.08.31.555720 |
| Devices mentioned | K914390 |
| Product codes mentioned | DDG, JCJ, JJH |
At a glance
- 1–9 FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1